Evidence map›Paper›PMID 26631721›Full record

ArticleThe Journal of biological chemistry2016

Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.

Toshiyuki Takasugi, Seiji Minegishi, Akiko Asada, Taro Saito, Hiroyuki Kawahara, Shin-ichi Hisanaga

Abstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. CDK5 targets p21Molecular medicine reports · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toshiyuki TakasugiFrom the Laboratory of Molecular Neuroscience and.
Seiji MinegishiFrom the Laboratory of Molecular Neuroscience and.
Akiko AsadaFrom the Laboratory of Molecular Neuroscience and.
Taro SaitoFrom the Laboratory of Molecular Neuroscience and.
Hiroyuki KawaharaLaboratory of Cellular Biochemistry, Department of Biological Sciences, and Graduate School of Sciences, Tokyo Metropolitan University, Mianami-osawa, Hachioji,Tokyo 192-0397, Japan.
Shin-ichi HisanagaFrom the Laboratory of Molecular Neuroscience and hisanaga-shinichi@tmu.ac.jp.ORCID http://orcid.org/0000-0002-7572-472X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cdk5 is a versatile protein kinase that is involved in various neuronal activities, such as the migration of newborn neurons, neurite outgrowth, synaptic regulation, and neurodegenerative diseases. Cdk5 requires the p35 regulatory subunit for activation. Because Cdk5 is more abundantly expressed in neurons compared with p35, the p35 protein levels determine the kinase activity of Cdk5. p35 is a protein with a short half-life that is degraded by proteasomes. Although ubiquitination of p35 has been previously reported, the degradation mechanism of p35 is not yet known. Here, we intended to identify the ubiquitination site(s) in p35. Because p35 is myristoylated at the N-terminal glycine, the possible ubiquitination sites are the lysine residues in p35. We mutated all 23 Lys residues to Arg (p35 23R), but p35 23R was still rapidly degraded by proteasomes at a rate similar to wild-type p35. The degradation of p35 23R in primary neurons and the Cdk5 activation ability of p35 23R suggested the occurrence of ubiquitin-independent degradation of p35 in physiological conditions. We found that p35 has the amino acid sequence similar to the ubiquitin-independent degron in the NKX3.1 homeodomain transcription factor. An Ala mutation at Pro-247 in the degron-like sequence made p35 stable. These results suggest that p35 can be degraded by two degradation pathways: ubiquitin-dependent and ubiquitin-independent. The rapid degradation of p35 by two different methods would be a mechanism to suppress the production of p25, which overactivates Cdk5 to induce neuronal cell death.

Indexed as

UbiquitinationAmino Acid SubstitutionAnimalsCell Line, TumorCells, CulturedCerebral CortexCyclin-Dependent Kinase 5Embryo, MammalianEnzyme ActivationHalf-LifeHEK293 CellsHumansLipoylationMice, Inbred ICRMutationNeuronsCdk5 protein, mouseCdk5r1 protein, mouseCyclin-Dependent Kinase 5PhosphotransferasesProteasome Endopeptidase ComplexRecombinant Proteinscyclin-dependent kinase 5cyclin-dependent kinase (CDK)degronneuronproteasomeprotein degradationserine/threonine protein kinaseubiquitin

Identifiers

PMID26631721
PMCPMC4813488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.